Literature DB >> 8389283

Regulation of extracellular signal-regulated protein kinase-1 (ERK-1; pp44/mitogen-activated protein kinase) by epidermal growth factor and nerve growth factor in PC12 cells: implication of ERK1 inhibitory activities.

P Peraldi1, J C Scimeca, C Filloux, E Van Obberghen.   

Abstract

In PC12 cells, extracellular signal-regulated kinase-1 (ERK1 or pp44/mitogen-activated protein kinase) is stimulated in response to epidermal growth factor (EGF) and nerve growth factor (NGF). This stimulation is rapid and short-lived after EGF activation. In contrast, NGF promotes a swift, but persistent, ERK1 stimulation. We took advantage of this difference in activation pattern to study the negative regulation of ERK1. Using antibodies to the C-terminus of ERK1, we performed in vitro reconstitution experiments with immunoprecipitated ERK1 from stimulated cells and extracts from PC12 cells incubated with EGF or NGF for various periods of times. Using this approach, we showed that extracts from unstimulated cells reduce ERK1 activity. Upon exposure of cells to NGF or EGF, we found that the inhibitory activity had a pattern opposite that of ERK1 phosphorylation and activity. Indeed, the highest ERK1 activation was associated with the lowest ERK1-repressing activity and vice versa. This ERK1 inhibitory activity was found to be sensitive mainly to sodium orthovanadate and to a lesser extent to zinc acetate. Interestingly, okadaic acid decreased ERK1-repressing activity from unstimulated cells when tested with ERK1 from 5-min NGF-treated cells, but not with ERK1 from 5-min EGF-treated cells. Hence, ERK1 appears to be regulated differently after stimulation of cells with EGF compared to NGF. We show that cell extracts promote ERK1 dephosphorylation. Indeed, we were able to detect a phosphatase activity toward in vivo phosphorylated ERK1 that was regulated differently after NGF and EGF treatments of the cells, and that has a profile of regulation similar to that of the ERK1 inhibitory activity. This regulatable phosphatase activity was also observed using in vitro phosphorylated ERK1. Taken together, our data provide evidence that ERK1 is negatively controlled by a phosphatase(s) that can undergo differential modulation depending on the stimuli used.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389283     DOI: 10.1210/endo.132.6.8389283

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

Review 2.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor.

Authors:  E Van Obberghen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 3.  Bistable switches as integrators and actuators during cell cycle progression.

Authors:  Wayne Stallaert; Katarzyna M Kedziora; Hui Xiao Chao; Jeremy E Purvis
Journal:  FEBS Lett       Date:  2019-10-16       Impact factor: 4.124

4.  Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity.

Authors:  F Viñals; J Pouysségur
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.

Authors:  Yu Zhou; Gail E Besner
Journal:  Neurosignals       Date:  2010-09-16

6.  NS-417, a novel compound with neurotrophic-like effects.

Authors:  Lone Dagø; Dan Peters; Morten Meyer; Barbara Hartz; Vibeke Kruse; Jørgen Drejer; Mette Grønborg
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

7.  Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation.

Authors:  S J Yarwood; J R Woodgett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

8.  Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase.

Authors:  P Peraldi; Z Zhao; C Filloux; E H Fischer; E Van Obberghen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 9.  Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.

Authors:  H S Earp; T L Dawson; X Li; H Yu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

10.  Differential regulation of SC1/PRDM4 and PRMT5 mediated protein arginine methylation by the nerve growth factor and the epidermal growth factor in PC12 cells.

Authors:  Alexandra Chittka
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.